| Financial Year |
March 31 2023 |
| Monetary Funds |
3,281,349,999.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
71,780,362.73 |
| Accounts Receivable |
724,306,179.99 |
| Advances to Suppliers |
96,497,314.52 |
| Other Receivables |
2,129,753.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,406,469,912.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,336,822.95 |
| Total Current Assets |
6,268,861,801.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
370,759,352.83 |
| Investment Properties |
-- |
| Fixed Assetes |
6,654,474,946.63 |
| Under-construction Projects |
3,545,190,249.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
363,648,013.74 |
| R&D expenses |
-- |
| Goodwill |
47,766,229.39 |
| Long-Term Deferred and Prepaid Expenses |
13,354,424.34 |
| Deferred Income Tax Assets |
220,367,247.30 |
| Other Non-Current Assets |
593,890,647.13 |
| Sub-Total of Non-Current Assets |
11,860,616,111.13 |
| Total Assets |
18,129,477,912.23 |
| Short-Term Loans |
315,043,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
151,685,749.35 |
| Accounts Payable |
770,928,050.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,716,714.35 |
| Taxes Payable |
13,189,695.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,534,478.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
247,259,498.83 |
| Other Current Liabilities |
1,405,152.66 |
| Sub-Total of Current Liabilities |
1,546,531,085.53 |
| Long-term Loans |
1,982,912,555.56 |
| Bonds Payable |
3,199,201,023.50 |
| Long-Term Accounts Payable |
1,196,666,666.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,612,414.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,740,004,487.30 |
| Total Liabilities |
8,286,535,572.83 |
| Paid-In Capital(Or Share Stock) |
676,848,359.00 |
| Capital Surplus |
5,557,176,711.11 |
| Surplus Reserve |
130,088,290.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,625,357,408.33 |
| Minority Stockholder's Interest |
1,627,004,108.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,215,938,230.63 |
| Owner's Equity（Stockholder's Equity） |
9,842,942,339.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,129,477,912.23 |
